Sparsentan
CAS 254740-64-2
Em Estoque
Sparsentan
Cat. No. STUB-API-SPARSENTANCAS 254740-64-2Em Estoque
Dados Técnicos
Cat. No.STUB-API-SPARSENTAN
CAS254740-64-2
Fórmula Mol.C32H40N4O5S
Peso Mol.592.762 g/mol
IUPAC2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide
SMILESCCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC
InChIInChI=1S/C32H40N4O5S/c1-5-7-14-29-33-32(17-10-11-18-32)31(37)36(29)20-24-15-16-26(25(19-24)21-40-6-2)27-12-8-9-13-28(27)42(38,39)35-30-22(3)23(4)41-34-30/h8-9,12-13,15-16,19H,5-7,10-11,14,17-18,20-21H2,1-4H3,(H,34,35)
Chave InChIWRFHGDPIDHPWIQ-UHFFFAOYSA-N
Pureza—
Descrição
Visão geral
Sparsentan is an FDA-approved medication used to treat primary immunoglobulin A nephropathy (IgAN) to help maintain kidney function and reduce protein in urine (proteinuria)
A Anant Labs fabrica e fornece impurezas de Sparsentan de alta qualidade para o mercado global. Nossas impurezas EP de Sparsentan são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
sparsentan254740-64-2RE-021FILSPARIPS433540esparsentanPS-433540sparsentanum9242RO5URM(1,1'-Biphenyl)-2-sulfonamide, 4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-
